|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.82 HKD | -0.46% |
|
+0.84% | -16.12% |
Business description: China Medical System Holdings Limited
Number of employees: 6,415
Sales by Activity: China Medical System Holdings Limited
| Fiscal Period: December | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
Integrated Business | - | - | - | - | 7.17B |
Skin Health Business | - | - | - | - | 1.07B |
Marketing, Promotion, Sales and Manufacturing of Pharmaceutical Products | 8.34B | 9.15B | 8.01B | 7.47B | - |
Elimination | - | - | - | - | -32.6M |
Geographical breakdown of sales: China Medical System Holdings Limited
| Fiscal Period: December | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
PRC | 8.34B | 9.15B | 8.01B | 7.47B | 8.21B |
Executive Committee: China Medical System Holdings Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Kong Lam
CEO | Chief Executive Officer | 61 | 2020-03-30 |
Yan Ling Chen
DFI | Director of Finance/CFO | 55 | - |
Fei Jiang
CIO | Chief Investment Officer | 50 | 2021-12-31 |
Wai Ming Wong
CTO | Chief Tech/Sci/R&D Officer | 66 | 2006-12-31 |
Cheng Lu
PRN | Corporate Officer/Principal | - | - |
Composition of the Board of Directors: China Medical System Holdings Limited
| Director | Title | Age | Since |
|---|---|---|---|
Kong Lam
CHM | Chairman | 61 | 2006-12-17 |
Yan Ling Chen
BRD | Director/Board Member | 55 | 2006-12-17 |
Chong Shun Leung
BRD | Director/Board Member | 60 | 2017-12-12 |
Ying Luo
BRD | Director/Board Member | 61 | 2020-03-30 |
Ching Fung
BRD | Director/Board Member | 57 | 2021-10-05 |
Holdings: China Medical System Holdings Limited
| Name | Stocks | % | Valuation |
|---|---|---|---|
| 5,497,000 | 0.23% | 7 M $ |
Company details: China Medical System Holdings Limited
China Medical System Holdings Ltd.
Majialong Chuangxin Building
518052, Shenzhen
+852 2369 7678
http://www.cms.net.cn
Group companies: China Medical System Holdings Limited
| Name | Category and Sector |
|---|---|
CMS Medical Venture Investment (HK) Ltd. | |
CMS Medical Venture Investment (HK) Ltd. |
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.46% | +0.84% | -1.28% | -10.28% | 3.36B | |
| +1.53% | +2.74% | +42.97% | +159.61% | 1,013B | |
| +0.47% | +5.16% | +54.55% | +50.06% | 574B | |
| +0.24% | +0.35% | +17.87% | +63.89% | 397B | |
| -0.37% | +4.97% | +21.24% | +15.95% | 324B | |
| +0.85% | +0.18% | +24.50% | +14.78% | 280B | |
| +2.10% | +4.92% | +25.30% | +33.80% | 273B | |
| +3.79% | +1.55% | +20.27% | +61.46% | 182B | |
| -0.19% | -0.46% | -45.32% | -48.35% | 194B | |
| +3.35% | -2.66% | +15.05% | +61.51% | 151B | |
| Average | +1.08% | +2.51% | +17.51% | +40.24% | 339.2B | |
| Weighted average by Cap. | +1.05% | +3.99% | +29.41% | +72.37% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 867 Stock
- Company China Medical System Holdings Limited
Select your edition
All financial news and data tailored to specific country editions
